In Washington, researchers used blood from a National Children’s Study biobank to identify more accurate reference intervals for various hormones and amino acids in newborns across a diverse population. The more defined reference intervals could help with earlier diagnosis of diseases like diabetes and pediatric cancer as well as lead to a better understanding of physical and neurological development. As we know, newborns are tiny and its often difficult to draw a significant amount of blood from them for testing, which has proven to be a challenge in the past for researchers to have enough blood to test and reference. The hope is with this research, doctors will have a more accurate reference interval to refer to when testing pediatric patients for developmental issues or diseases.
Latest article
World Animal Protection launches AI-Powered cultivated meat chatbot
In London, animal advocacy group World Animal Protection has partnered with AI software company PubTrawlr to unveil Cultivator, the first-ever chatbot dedicated to cultivated...
DOE awards Hempitecture $8.42 million to boost hemp fiber manufacturing in Tennessee
In Idaho, sustainable building materials firm Hempitecture has been awarded $8.42 million in funding from the U.S. Department of Energy under the Biden-Harris Administration’s...
CJ Biomaterials PHA earns compostability certification
In Massachusetts, CJ Biomaterials, a division of South Korea's CJ CheilJedang, has received certification from the Biodegradable Products Institute (BPI) for its range of...